OTC Markets Group uses cookies and similar technologies to help us understand how you use our websites, as further disclosed in our Privacy Policy. Our Terms of Service contain important information including restrictions on your use of our websites. By clicking “Accept”, or by continuing to use our websites, you consent to the use of cookies and agree to the terms of the OTC Markets Group Privacy Policy and Terms of Service.
SPHRY
Starpharma Holdings Ltd.
Sponsored ADR (1 ADS : 10 Ordinary)
0.672
0.00
0.00%
0.5588 / 0.7364 (4700 x 5700)
Real-Time Best Bid & Ask: 05:00pm 07/17/2025
Delayed (15 Min) Trade Data: 12:00am 07/14/2025
0.00
N/A
0
Market Cap calculated only for this class of securities.
28,104,705
Real-Time Level 2 Quote
Trade Data
News
Filings and Disclosure
Company Description
Starpharma Holdings Limited (ASX: SPL, US OTC: SPHRY) is an innovative biotechnology company with two decades of experience in advancing dendrimer technology from the lab to the patient. Our mission is to help patients with significant illnesses, such as cancer, achieve improved health outcomes and quality of life through the application of our unique dendrimer technology.
Videos
Joined OTCQX 03/2007
The Company Profile data was verified by the issuer within the previous 6 months.
This security is not a Penny Stock as defined in SEC Rule 240.3a51-1.
This company has certified to OTC Markets Group that it is eligible to rely on the exemption from registration under Securities and Exchange Act Rule 12g3-2(b).
The Company’s board of directors includes at least two Independent Directors.
Securities
Other Starpharma Holdings Ltd. Securities
Subscribe to Our Newsletter
Stay up to date on the latest company news, industry trends and regulatory changes that affect our markets and learn about members of our community.
Loading...
Symbol
OTCM
Last
57.50
Change
0.50 (0.88%)
Bid
57.33
Ask
57.60
Volume
17414
Time
00:00
